Loading...
 
Toggle Health Problems and D

Vitamin D recommendations should reduce Rickets (but not much else) - March 2016

European Food Safety Authority March 2016 posted draft for comment:
Scientific Opinion on Dietary Reference Values for vitamin D

 Download the PDF from Vitamin D Life

EFSA, proposes:
20 ng level and 600 IU intake (with ZERO for age 0 to 6 months)

20 nanograms is enough to deal with Rickets
   but 40+ nanograms is needed for other BONE and BODY health

Benefit of Vitamin D vs level @ /is.gd/Vitdsports

Is 50 ng of vitamin D too high, just right, or not enough has the following summary chart

see wikipage: http://www.vitad.org/tiki-index.php?page_id=1293

  • Virtually all studes define 30 ng as sufficient
  • Many experts say 40 ng is good
  • Some experts say 50 ng is much better for disease prevention
  • Some experts say 50 ng is too much
    But some experts feel 50 ng is not enough to TREAT diseases

EFSA summarizes some current recomendations

ADULT

Image

CHILD

Image

PREGNANT/LACTATING

Image

SACN UK Scientific Advisory Committee on Nutrition
D-A-CH GermanyDeutschland- Austria- Confoederatio Helvetica
NCM Nordic CountriesNordic Council of Ministers
NL Netherlands
IOM U.S. Institute of Medicine of the National Academy of Sciences
WHOGlobe World Health Organization
AfssaFranceAgence française de sécurité sanitaire des aliments
SCF Europe Scientific Committee for Food
DH UK UK Department of Health

Virtually all recommendations fail to notice


Falls in Vitamin D Life


Europe in Vitamin D Life


Death due to low vitamin D in Vitamin D Life


Pregnancy and Vitamin D in Vitamin D Life

Healthy pregnancies need lots of vitamin D has the following summary

Problem
Vit. D
Reduces
Evidence
0. Chance of not conceiving3.4 times Observe
1. Miscarriage 2.5 times Observe
2. Pre-eclampsia 3.6 timesRCT
3. Gestational Diabetes 3 times RCT
4. Good 2nd trimester sleep quality 3.5 times Observe
5. Premature birth 2 times RCT
6. C-section - unplanned 1.6 timesObserve
     Stillbirth - OMEGA-3 4 timesRCT - Omega-3
7. Depression AFTER pregnancy 1.4 times RCT
8. Small for Gestational Age 1.6 times meta-analysis
9. Infant height, weight, head size
     within normal limits
RCT
10. Childhood Wheezing 1.3 times RCT
11. Additional child is Autistic 4 times Intervention
12.Young adult Multiple Sclerosis 1.9 timesObserve
13. Preeclampsia in young adult 3.5 timesRCT
14. Good motor skills @ age 31.4 times Observe
15. Childhood Mite allergy 5 times RCT
16. Childhood Respiratory Tract visits 2.5 times RCT

RCT = Randomized Controlled Trial


Bones problems in Vitamin D Life

See also Vitamin D Life


EFSA Abstract

Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) derived Dietary Reference Values (DRVs) for vitamin D. The Panel considers that serum 25(OH)D concentration, which reflects the amount of vitamin D attained from both cutaneous synthesis and dietary sources, can be used as biomarker of vitamin D status in adult and children populations. The Panel notes that the evidence on the relationship between serum 25(OH)D concentration and musculoskeletal health outcomes in adults, infants and children, and adverse pregnancy-related health outcomes, is widely variable. The Panel considers that Average Requirements and Population Reference Intakes for vitamin D cannot be derived, and therefore defines Adequate Intakes (AIs), for all population groups. Taking into account the overall evidence and uncertainties, the Panel considers that a serum 25(OH)D concentration of 50 nmol/L is a suitable target value for all population groups, in view of setting the AIs.

  • For adults, an AI for vitamin D is set at 15 ug/day, based on a meta-regression analysis and considering that, at this intake, most of the population will achieve a serum 25(OH)D concentration near or above the target of 50 nmol/L.
  • For children aged 1-17 years, an AI for vitamin D is set at 15 ug/day, based on the meta-regression analysis.
  • For infants aged 7-11 months, an AI for vitamin D is set at 10 ug/day, based on trials in infants.
  • For pregnant and lactating women, the Panel sets the same AI as for non-pregnant non-lactating women, i.e. 15 ug/day.

The Panel underlines that the meta-regression was done on data collected under conditions of minimal cutaneous vitamin D synthesis.
In the presence of cutaneous vitamin D synthesis, the requirement for dietary vitamin D is lower or may even be zero.

Attached files

ID Name Comment Uploaded Size Downloads
6494 NL Vitamin D.pdf admin 22 Mar, 2016 981.06 Kb 1038
6493 EFSA T3 Pregnant.jpg admin 22 Mar, 2016 37.21 Kb 1158
6492 EFSA T2 Children.jpg admin 22 Mar, 2016 84.94 Kb 1291
6491 EFSA T1 Adults.jpg admin 22 Mar, 2016 65.17 Kb 1216
6490 EFSA March 2016.pdf admin 22 Mar, 2016 4.17 Mb 5968